Takeda Pharmaceutical (TAK) Reaches a Fresh Annual High at $21.44

As seen on the 24/7 Wall St. homepage on November 13, 2026.

TAK Takeda Pharmaceutical
52-week high
$21.44
+0.89% vs prior 52-week high · Nov 5, 2026
$22$18$13

Takeda's $21.44 close tops the high it set on Nov. 5 by 0.89%, extending a steady climb in the large-cap drugmaker.

Related stocks today
  • CORCencoraCustomer+2.8%
    Jun 17, 6:06 AM ET · SEC 10-K
  • CAHCardinal HealthCustomer+1.1%
    Mar 31, 2026 · SEC 10-K
  • JNJJohnson & JohnsonPartner+0.9%
    Jun 17, 6:06 AM ET · SEC 10-K

Moves: Nov 13, 2026 · Alpha Vantage daily close

8 more related stocks · 1 has no US listing

Continue ReadingShow less

Takeda Pharmaceutical closed at $21.44 on November 13, 2026, rising 0.89% above the prior high it had set on November 5. That earlier peak had stood for less than two weeks before today's session pushed through it, a sign the upward momentum has not yet stalled at resistance.

After a long, uneven climb from the low teens over the past year, the move to $21.44 marks a substantial gain from the lower end of that range.

Sponsored

Customers and partners disclosed in Takeda's SEC 10-K also advanced in the same session, with Cencora leading the group at 2.81%. Broad strength across related names points to sector-level tailwinds rather than a single catalyst.

For investors already holding the stock, a close above the prior high is a technically meaningful moment, since levels that previously acted as a ceiling can become support on a pullback. Keep an eye on whether today's close holds.

Mentioned: TAK, TKPHF, COR, CAH, JNJ